R&D Leaders' Forum Autumn 2003

October 6 - 8, 2003
Hotel President Wilson
Geneva (Switzerland)
Contact: Phacilitate

Cenix Participant:

Dr. Christophe Echeverri (CEO/CSO)
"Exploring the promise and reality of siRNA's and their potential to alleviate the target validation bottleneck:
- How they can be integrated into the pipeline as a whole?
- When will the technology be robust enough to use in vivo?"

Wednesday, October 8, 2003, 7:00 pm

Session 2: Improving the quality of validated targets to increase the productivity of drug development